1-18 of 18
Weili Sun
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Teclistamab, Daratumumab, and Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma: Results from the Majestec-2 Cohort a and Trimm-2 Studies

Anita D'Souza, Luciano J. Costa, Jesús F. San-Miguel, Jesus G Berdeja, Daniel Morillo Giles, Cyrille Touzeau, John T McKay, Bhagirathbhai Dholaria, Thomas G Martin, Aurore Perrot, Albert Oriol, Anna Sureda Balari, Thomas Prior, Debopriya Ghosh, Lijuan Kang, Julie S Larsen, Hein Ludlage, Lien Vandenberk, Lingling Chen, Bas D Koster, Weili Sun, Rachel Kobos, Emma Searle, Jeffrey V Matous, Ajai Chari, Tobias Kampfenkel
Journal: Blood
Blood (2024) 144 (Supplement 1): 495.
https://doi.org/10.1182/blood-2024-200181
Published: 2024
Journal Articles

Pharmacodynamic Signatures and Correlatives of Response in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Talquetamab or Teclistamab Plus Daratumumab and Pomalidomide

Deeksha Vishwamitra, Sheri Skerget, Diana Cortes, Kalpana Bakshi, Lien Vandenberk, Weili Sun, Jaszianne Tolbert, Colleen Kane, Hein Ludlage, Bas D Koster, Julie S Larsen, Tobias Kampfenkel, Ching Li, Farheen Zishan, Thomas Prior, Luciano J. Costa, Jesus G Berdeja, Cyrille Touzeau, Aurore Perrot, Emma Searle, Jeffrey V Matous, Ajai Chari, Donna Reece, Manisha Bhutani, Bhagirathbhai Dholaria, Anita D'Souza, Thomas G Martin, John T. McKay, Alfred L Garfall, Amrita Y Krishnan, Niels W.C.J. van de Donk, Nizar J. Bahlis, Ricardo M. Attar
Journal: Blood
Blood (2024) 144 (Supplement 1): 594.
https://doi.org/10.1182/blood-2024-200300
Published: 2024
Journal Articles

Targeting PRMT1-mediated FLT3 methylation disrupts maintenance of MLL -rearranged acute lymphoblastic leukemia

Yinghui Zhu, Xin He, Yi-Chun Lin, Haojie Dong, Lei Zhang, Xianwei Chen, Zhihao Wang, Yudao Shen, Min Li, Hanying Wang, Jie Sun, Le Xuan Nguyen, Han Zhang, Wenjuan Jiang, Yanzhong Yang, Jianjun Chen, Markus Müschen, Chun-Wei Chen, Marina Y. Konopleva, Weili Sun, Jian Jin, Nadia Carlesso, Guido Marcucci, Yun Luo, Ling Li
Journal: Blood
Blood (2019) 134 (15): 1257–1268.
https://doi.org/10.1182/blood.2019002457
Published: 2019
Includes: Supplemental data
Journal Articles

Response to Venetoclax and Hypomethylating Agents Among Prognostic Risk Groups and Genetic Subtypes of Acute Myeloid Leukemia

Ibrahim Aldoss, MD, Dongyun Yang, PhD, Raju Pillai, MD, James F Sanchez, PhD, Ahmed Aribi, MD, Haris Ali, MD, Karamjeet S Sandhu, MD, Monzr Al Malki, MD, Matthew Mei, MD, Amandeep Salhotra, MD, Samer K. Khaled, MD, Ryotaro Nakamura, MD, Weili Sun, MD PhD, Margaret R O'Donnell, MD, David S Snyder, MD, Anthony S. Stein, MD, Stephen J Forman, Guido Marcucci, Vinod A. Pullarkat, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 334.
https://doi.org/10.1182/blood-2018-99-113670
Published: 2018
Journal Articles

Inhibition of PRMT1 Mediated FLT3 Arginine Methylation As a Potent Therapeutic Strategy for MLL-r ALL

Yinghui Zhu, PhD, Xin He, PhD, Haojie Dong, PhD, Jie Sun, PhD, Hanying Wang, PhD, Lei Zhang, PhD, Yunan Miao, PhD, Jian Jin, PhD, Yudao Shen, PhD, Jianjun Chen, PhD, Markus Muschen, MD, Chun-Wei Chen, PhD, Marina Y. Konopleva, MD PhD, Weili Sun, MD PhD, Bin Zhang, PhD, Ya-Huei Kuo, PhD, Nadia Carlesso, MD PhD, Guido Marcucci, Ling Li, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 892.
https://doi.org/10.1182/blood-2018-99-115139
Published: 2018
Journal Articles

A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium

Clinical Trials & Observations
Weili Sun, Timothy Triche, Jr, Jemily Malvar, Paul Gaynon, Richard Sposto, Xiaojing Yang, Henrique Bittencourt, Andrew E. Place, Yoav Messinger, Chris Fraser, Luciano Dalla-Pozza, Bodour Salhia, Peter Jones, Alan S. Wayne, Lia Gore, Todd M. Cooper, Gangning Liang
Journal: Blood
Blood (2018) 131 (10): 1145–1148.
https://doi.org/10.1182/blood-2017-09-803809
Published: 2018
Includes: Supplemental data
Journal Articles

HLA-Haploidentical Stem Cell Transplant with Pre-Transplant Immunosuppression for Patients with Sickle Cell Disease

Anna B Pawlowska, MD, Nicole Karras, MD, Jerry C Cheng, MD, Weili Sun, MD PhD, Leo D Wang, MD PhD, Alison D Bell, DNP, CPNP, Lisa Gutierrez, PNP, Joseph Rosenthal, MD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 5478.
https://doi.org/10.1182/blood.V130.Suppl_1.5478.5478
Published: 2017
Journal Articles

CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Stephen P. Hunger, MD, Vaskar Saha, MD PhD, Meenakshi Devidas, Maria Grazia Valsecchi, Julie Gastier Foster, Gianni Cazzaniga, PhD, Shalini C. Reshmi, PhD, Michael Borowitz, MD PhD, Anthony Moorman, Nyla A. Heerema, PhD, Andrew J. Carroll, III, PhD, Phillip Barnette, M. Monica Monica Gramatges, MD, Kelly Maloney, MD, Weili Sun, MD PhD, Rene Swanink, Amanda Termuhlen, Mignon L. Loh, MD, Elizabeth A. Raetz, MD, Lewis B. Silverman, MD, Martin Schrappe, MD PhD, Kirk R. Schultz, William Slayton, MD, Diane Healey, Andrea Biondi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 98.
https://doi.org/10.1182/blood.V130.Suppl_1.98.98
Published: 2017
Journal Articles

Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia

Clinical Trials & Observations
Alan S. Wayne, Nirali N. Shah, Deepa Bhojwani, Lewis B. Silverman, James A. Whitlock, Maryalice Stetler-Stevenson, Weili Sun, Meina Liang, Jie Yang, Robert J. Kreitman, Mark C. Lanasa, Ira Pastan
Journal: Blood
Blood (2017) 130 (14): 1620–1627.
https://doi.org/10.1182/blood-2017-02-749101
Published: 2017
Includes: Supplemental data
Journal Articles

Re-Induction Outcome for Pediatric Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Therapeutic Advances in Childhood Leukemia Consortium

Weili Sun, MDPhD, Jemily Malvar, MS, Richard Sposto, PhD, Anupam Verma, MD, Jennifer J. Wilkes, MD, Robyn M. Dennis, MD, Kenneth Matthew Heym, MD, Elena Eckroth, CCRC, Jeannette Vandergiesse, BA, CCRP, Paul S. Gaynon, MD, Alan S. Wayne, MD, James A. Whitlock, MD
Journal: Blood
Blood (2015) 126 (23): 3760.
https://doi.org/10.1182/blood.V126.23.3760.3760
Published: 2015
Journal Articles

A Phase 1 Study of Azacitidine (AZA) in Combination with Fludarabine and Cytarabine in Relapse/Refractory Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

Weili Sun, MDPhD, Paul S Gaynon, MD, Richard Sposto, PhD, Henrique Bittencourt, MD, Andrew E. Place, MDPhD, Yoav H Messinger, MD, Chris Fraser, MD, Luciano Dalla-Pozza, MD, Jeannette van der Giessen, BA, CCRP, Elena Eckroth, CCRC, Xiaojing Yang, PhD, Gangning Liang, PhD, Peter A. Jones, PhD DSc, Alan S. Wayne, MD, Todd Cooper, DO
Journal: Blood
Blood (2014) 124 (21): 3764.
https://doi.org/10.1182/blood.V124.21.3764.3764
Published: 2014
Journal Articles

The UK ALLR3 Chemotherapy Regimen for Relapsed/Refractory Acute Lymphoblastic Leukemia of Childhood: A Multi-Institutional Retrospective Study of Treatment Related Adverse Events

Weili Sun, MDPhD, Alison Marie Smith, BS, Orgal Etan, MD, Richard Sposto, PhD, Jennifer J. Wilkes, MD, Rebecca A Gardner, MD, Hur Minjun, Vanessa Pineros, Emily Olson, MD, Yijuin Tan, Susan R. Rheingold, MD, Michael J. Burke, MD, Alan S. Wayne, MD
Journal: Blood
Blood (2014) 124 (21): 3647.
https://doi.org/10.1182/blood.V124.21.3647.3647
Published: 2014
Journal Articles

Critical Role of Hem1 in Hematopoietic Cell Chemotaxis and Innate Immunity to S. Pneumoniae

Robert B. Lorsbach, MD, PhD, Yoon-Sang Kim, MD, PhD, Jennifer Moore, B.S., Hope Smith-Sielicki, B.S., Tiffany M. Jones, B.S., Weili Sun, M.D., Ph.D, Elaine Tuomanen, M.D., James R. Downing, M.D.
Journal: Blood
Blood (2006) 108 (11): 1630.
https://doi.org/10.1182/blood.V108.11.1630.1630
Published: 2006
Journal Articles

Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors

Weili Sun, James R. Downing
Journal: Blood
Blood (2004) 104 (12): 3565–3572.
https://doi.org/10.1182/blood-2003-12-4349
Published: 2004
Includes: Supplemental data
Journal Articles

The Combined Expression of AML1-ETO and Oncogenic RAS Is Insufficient To Induce Acute Myeloid Leukemia (AML).

Christian Flotho, MD, Weili Sun, MD, PHD, Sheila Shurtleff, PHD, Shouli Yang, PHD, James R. Downing, MD
Journal: Blood
Blood (2004) 104 (11): 2557.
https://doi.org/10.1182/blood.V104.11.2557.2557
Published: 2004
Journal Articles

Purification of c-Kit-Negative Hematopoietic Stem Cells from Runx1-GFP Knock-In Mice.

Robert B. Lorsbach, MD, PhD., Sonny O. Ang, PhD, Weili Sun, PhD, Jennifer Moore, BS, James R. Downing, MD
Journal: Blood
Blood (2004) 104 (11): 135.
https://doi.org/10.1182/blood.V104.11.135.135
Published: 2004
Journal Articles

Mice with AML1 ( Runx1 ) Haploinsufficiency Have Significant Platelet Abnormalities That Accurately Mimic Those Seen in Human Patients with Germ Line Inactivating Mutations in AML1 .

Weili Sun, M.D., Ph.D, Shirley Steward, Tamara Pestina, Ph.D, Carl W. Jackson, Ph.D, James R. Downing, M.D.
Journal: Blood
Blood (2004) 104 (11): 1595.
https://doi.org/10.1182/blood.V104.11.1595.1595
Published: 2004
Journal Articles

Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression

Robert B. Lorsbach, Jennifer Moore, Sonny O. Ang, Weili Sun, Noel Lenny, James R. Downing
Journal: Blood
Blood (2004) 103 (7): 2522–2529.
https://doi.org/10.1182/blood-2003-07-2439
Published: 2004